Tie-Lin Wang, Ph.D.

Nearly 20 years of successful track record in drug discovery with broad expertise in R&D management and strong leadership skills.

Served as Chief Scientific Officer at Luoxin Pharmaceuticals (Shanghai),multiple drug candidates have been advanced to clinical trials under his leadership.

Served as Vice President of drug discovery at ChemPartner and Associate Director at Exelixis in charge of multiple collaborative projects with multinational pharmaceutical companies, with one compound is currently in a Phase II clinical trial.

Served as Associate Director at Exelixis and led his team to drive four compounds into clinical development stages. Among them, Minnebro has been approved and launched in Japan for the treatment of essential hypertension.

Ph.D. degree in organic chemistry from Shanghai Institute of Organic Chemistry, Sinica Academia; postdoctoral training in the U.S. included his research in the lab of Sir Derek Barton, a Nobel laureate, at Texas A&M University.

Co-inventor of more than 70 granted patents.